Protein Expression Market Updates

Protein Expression Market size was valued at USD 3.29 Billion in 2023 and is poised to grow from USD 3.73 Billion in 2024 to USD 10.11 Billion by 2032, growing at a CAGR of 13.3% during the forecast period (2025-2032).

The protein expression market is extremely dynamic with immense competition among the market players and startups. The market leaders are constantly investing in research and development to maintain their market share. Companies are also engaging in collaborations and partnerships for increasing innovation and product diversity. This unique market setting helps in the growth of technological innovation resulting in the advent of novel protein systems and solutions. 'Thermo Fisher Scientific, Inc. (US) ', 'Merck KGaA (Germany) ', 'Genscript Biotech Corporation (China) ', 'Agilent Technologies Inc. (US) ', 'Takara Bio, Inc. (Japan) ', 'Bio-Rad Laboratories, Inc. (US) ', 'Qiagen N.V. (Netherlands) ', 'Charles River Laboratories International, Inc. (US) ', 'Danaher Corporation (US) ', 'Sartorius AG (Germany) ', 'Corning Incorporated (US) ', 'Fujifilm Irvine Scientific, Inc. (US) ', 'Lonza Group AG (Switzerland) ', 'Bioneer Corporation (South Korea) ', 'Promega Corporation (US) ', 'Oxford Expression Technologies Ltd. (UK) ', 'Proteogenix (France) ', 'Abeomics Inc. (US) ', 'New England Biolabs, Inc. (US) ', 'Promab Biotechnologies (US) ', 'Sino Biological, Inc. (China) ', 'Jena Bioscience (Germany) ', 'Lifesensors, Inc. (US) ', 'Leading Biology, Inc. (US) ', 'Peak Proteins (UK)'

The protein expression market is expanding rapidly owing to the massive scale manufacturing of protein by utilizing E. coli bacteria. This bacteria is the most frequently utilized artificial expression host and is massively used due to their genomic and sequencing system. It is responsible for smoothing the cloning processes and making E. coli host the most preferred choice in pharmaceutical sector. Moreover, this procedure also increases the strength of binding in promoter region 7 and helps in transcription.

Advent of Microfluidics: The emergence of microfluidics technology for protein expression is propelling the growth of the market. It can manipulate fluids in microscale devices and enable accurate control over less amount of fluids. This technology is perfect for protein expression. Microfluidic devices can develop small channels and chambers that offer a setting for protein expression. It allows quick and effective screening of various conditions.

Based on region, North America is dominating the protein expression market with the largest market share. This region is growing immensely due to the presence of major players combined with increasing funds for research & development with robust lines of biosimilar. Furthermore, the companies in this region are also engaging in collaboration with academic facilities. This has become one of the major drivers of the growth of the market as it is helping them to introduce new innovative products to the market. Moreover, the rising demand for therapeutic proteins and monoclonal antibodies is also increasing due to the advancements in biotechnology. The popularity of personalized medicine and the increasing prevalence of chronic diseases are also propelling the growth of the market in this region. These factors are increasing the demand for protein expression market in North America.